Source: Annual Congress 2007 - Biomarkers in inflammatory lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bazyka, L. Shvayko, K. Bazyka (Kiev, Ukraine). Cellular biomarkers in chronic obstructive pulmonary disease in radiation exposed. Eur Respir J 2007; 30: Suppl. 51, 917

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) at the remote period after radiation exposure Source: Eur Respir J 2007; 30: Suppl. 51, 338s Year: 2007 Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Novel compounds for WNT/ß-catenin induced lung repair in chronic obstructive pulmonary disease Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Genetic risks in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) and smoking cessation in exposed to low-dose radiation Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Application of erdosteine in the treatment of occupational chronic obstructive pulmonary disease Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Does asbestos exposure cause chronic obstructive lung disease? Source: Eur Respir J 2007; 30: Suppl. 51, 159s Year: 2007 The impact of airborne occupational exposure in chronic obstructive pulmonary disease Source: Annual Congress 2010 - The impact of airborne occupational exposure in COPD Year: 2010 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Cardiac response to exercise in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases Year: 2009 Oxidant metabolism in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 14S-27S Year: 2003